Report Detail
Global Somatostatin Market Growth 2019-2024
- RnM2938705 |
- 13 February, 2019 |
- Global |
- 162 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Somatostatin is one of the fastest growing medical Products in recent years in China. China is also the world's most rapid expansion Market. Rapid growth numbers of general hospital form a strong Market Demand of Somatostatin, especially the demand of second class and below second class hospital.
As the analogue is expanding in the market, and the price of Somatostatin not decreasing so much, Somatostatin will limited in many regions, like North America and EU. Even though the analogue and regional limited, the consumption of Somatostatin is keeping quick growth rate.
According to this study, over the next five years the Somatostatin market will register a 11.5% CAGR in terms of revenue, the global market size will reach US$ 370 million by 2024, from US$ 210 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Somatostatin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Somatostatin market by product type, application, key manufacturers and key regions and countries.
This study considers the Somatostatin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
0.25
0.75
3
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Application I
Application II
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Somatostatin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Somatostatin market by identifying its various subsegments.
Focuses on the key global Somatostatin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Somatostatin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Somatostatin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Somatostatin Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Somatostatin Consumption 2014-2024
- 2.1.2 Somatostatin Consumption CAGR by Region
- 2.2 Somatostatin Segment by Type
- 2.2.1 0.25
- 2.2.2 0.75
- 2.2.3 3
- 2.3 Somatostatin Consumption by Type
- 2.3.1 Global Somatostatin Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Somatostatin Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Somatostatin Sale Price by Type (2014-2019)
- 2.4 Somatostatin Segment by Application
- 2.4.1 Application I
- 2.4.2 Application II
- 2.5 Somatostatin Consumption by Application
- 2.5.1 Global Somatostatin Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Somatostatin Value and Market Share by Application (2014-2019)
- 2.5.3 Global Somatostatin Sale Price by Application (2014-2019)
3 Global Somatostatin by Players
- 3.1 Global Somatostatin Sales Market Share by Players
- 3.1.1 Global Somatostatin Sales by Players (2017-2019)
- 3.1.2 Global Somatostatin Sales Market Share by Players (2017-2019)
- 3.2 Global Somatostatin Revenue Market Share by Players
- 3.2.1 Global Somatostatin Revenue by Players (2017-2019)
- 3.2.2 Global Somatostatin Revenue Market Share by Players (2017-2019)
- 3.3 Global Somatostatin Sale Price by Players
- 3.4 Global Somatostatin Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Somatostatin Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Somatostatin Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Somatostatin by Regions
- 4.1 Somatostatin by Regions
- 4.1.1 Global Somatostatin Consumption by Regions
- 4.1.2 Global Somatostatin Value by Regions
- 4.2 Americas Somatostatin Consumption Growth
- 4.3 APAC Somatostatin Consumption Growth
- 4.4 Europe Somatostatin Consumption Growth
- 4.5 Middle East & Africa Somatostatin Consumption Growth
5 Americas
- 5.1 Americas Somatostatin Consumption by Countries
- 5.1.1 Americas Somatostatin Consumption by Countries (2014-2019)
- 5.1.2 Americas Somatostatin Value by Countries (2014-2019)
- 5.2 Americas Somatostatin Consumption by Type
- 5.3 Americas Somatostatin Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Somatostatin Consumption by Countries
- 6.1.1 APAC Somatostatin Consumption by Countries (2014-2019)
- 6.1.2 APAC Somatostatin Value by Countries (2014-2019)
- 6.2 APAC Somatostatin Consumption by Type
- 6.3 APAC Somatostatin Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Somatostatin by Countries
- 7.1.1 Europe Somatostatin Consumption by Countries (2014-2019)
- 7.1.2 Europe Somatostatin Value by Countries (2014-2019)
- 7.2 Europe Somatostatin Consumption by Type
- 7.3 Europe Somatostatin Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Somatostatin by Countries
- 8.1.1 Middle East & Africa Somatostatin Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Somatostatin Value by Countries (2014-2019)
- 8.2 Middle East & Africa Somatostatin Consumption by Type
- 8.3 Middle East & Africa Somatostatin Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Somatostatin Distributors
- 10.3 Somatostatin Customer
11 Global Somatostatin Market Forecast
- 11.1 Global Somatostatin Consumption Forecast (2019-2024)
- 11.2 Global Somatostatin Forecast by Regions
- 11.2.1 Global Somatostatin Forecast by Regions (2019-2024)
- 11.2.2 Global Somatostatin Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Somatostatin Forecast by Type
- 11.8 Global Somatostatin Forecast by Application
12 Key Players Analysis
- 12.1 Merck (Schweiz) AG
- 12.1.1 Company Details
- 12.1.2 Somatostatin Product Offered
- 12.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Merck (Schweiz) AG News
- 12.2 SANOFI-AVENTIS FRANCE
- 12.2.1 Company Details
- 12.2.2 Somatostatin Product Offered
- 12.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 SANOFI-AVENTIS FRANCE News
- 12.3 Lyomark Pharma GmbH
- 12.3.1 Company Details
- 12.3.2 Somatostatin Product Offered
- 12.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Lyomark Pharma GmbH News
- 12.4 ALFA WASSERMANN S.p.A.
- 12.4.1 Company Details
- 12.4.2 Somatostatin Product Offered
- 12.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 ALFA WASSERMANN S.p.A. News
- 12.5 Polypeptide Laboratories, Inc
- 12.5.1 Company Details
- 12.5.2 Somatostatin Product Offered
- 12.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Polypeptide Laboratories, Inc News
- 12.6 SAMARTH
- 12.6.1 Company Details
- 12.6.2 Somatostatin Product Offered
- 12.6.3 SAMARTH Somatostatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 SAMARTH News
- 12.7 UBPL
- 12.7.1 Company Details
- 12.7.2 Somatostatin Product Offered
- 12.7.3 UBPL Somatostatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 UBPL News
- 12.8 HYBIO
- 12.8.1 Company Details
- 12.8.2 Somatostatin Product Offered
- 12.8.3 HYBIO Somatostatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 HYBIO News
- 12.9 TianTaiShan
- 12.9.1 Company Details
- 12.9.2 Somatostatin Product Offered
- 12.9.3 TianTaiShan Somatostatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 TianTaiShan News
- 12.10 Yangtze River
- 12.10.1 Company Details
- 12.10.2 Somatostatin Product Offered
- 12.10.3 Yangtze River Somatostatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Yangtze River News
- 12.11 Siyao
- 12.12 Shuangcheng
- 12.13 Hainan Zhonghe
- 12.14 SL PHARM
- 12.15 Wuhan Hualong
- 12.16 Qingdao Guoda
- 12.17 Chengdu Shengnuo
- 12.18 Longjin
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Somatostatin . Industry analysis & Market Report on Somatostatin is a syndicated market report, published as Global Somatostatin Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Somatostatin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
